Aroa Biosurgery Limited (ARX.AX)
ASX - ASX Delayed price. Currency in AUD
Add to watchlist
At close: 03:03PM AEDT
| Previous close | 1.1650 |
| Open | 1.1600 |
| Bid | 1.1300 x 2041500 |
| Ask | 1.1450 x 261700 |
| Day's range | 1.1300 - 1.1700 |
| 52-week range | 0.6150 - 1.2450 |
| Volume | |
| Avg. volume | 420,862 |
| Market cap | 392.86M |
| Beta (5Y monthly) | 0.67 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0220 |
| Earnings date | 31 Jan 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 1.31 |
- Simply Wall St.
Aroa Biosurgery Limited (ASX:ARX) Is Expected To Breakeven In The Near Future
Aroa Biosurgery Limited ( ASX:ARX ) is possibly approaching a major achievement in its business, so we would like to...
- PR Newswire
AROA BIOSURGERY ANNOUNCES HALF YEAR RESULTS
Today New Zealand based soft-tissue regeneration company Aroa Biosurgery (AROA, the Company) is pleased to announce financial results for H1 FY23. With fewer COVID-19 related disruptions, the Company has entered FY23 with momentum and delivered strong financial results.
- PR Newswire
DR CATHERINE MOHR TO JOIN BOARD OF MEDTECH COMPANY AROA BIOSURGERY
New Zealand based soft tissue regeneration company Aroa Biosurgery (AROA) is delighted to announce the appointment of award-winning medical researcher and inventor, Dr. Catherine Mohr as a Non-Executive Director to the board.
© 2023 Yahoo. All rights reserved.
